straight labs bpc 157 BPC-157 Dosing (Common Protocols) 🔹 Oral / Subcutaneous • 500 mcg daily • Duration: 6 weeks 🔹 Intramuscular / Peritendinous • 1 mg daily • Duration: 6 weeks ⚠️ Note: Not approved Sublingual BPC-157 - TruHealth Physical

Fresh needles maintain sterility standards throughout the vials use

Solutions for Chronic Inflammation with GLOW Peptide Therapy: The GLOW Peptide protocol directly targets this inflammatory cascade

the culmination of this effort was dihexa, a dihexa pharmacokinetic characterization of dihexa included in this study indicated that it was stable in serum, had a long circulating half-life, and penetrated the BBB

The KLOW blend adds a fourth peptide, KPV (10 mg), on top of the GLOW composition for anti-inflammatory pathway coverage, totalling 80 mg across four peptides

Safety Disclaimer BPC-157 is not FDA approved for general medical use